ES2018479B3 - Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica. - Google Patents

Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica.

Info

Publication number
ES2018479B3
ES2018479B3 ES86907000T ES86907000T ES2018479B3 ES 2018479 B3 ES2018479 B3 ES 2018479B3 ES 86907000 T ES86907000 T ES 86907000T ES 86907000 T ES86907000 T ES 86907000T ES 2018479 B3 ES2018479 B3 ES 2018479B3
Authority
ES
Spain
Prior art keywords
enteric preparation
obesity
produce
treatment
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86907000T
Other languages
English (en)
Inventor
Conny Bogentoft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of ES2018479B3 publication Critical patent/ES2018479B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de una sustancia hidrófoba que es un ácido graso saturado o insaturado con 14-22 átomos de carbono, o ácido láurico, o una sal fisiológicamente aceptable de los mismo, o un éster de uno o más de dichos ácidos y un alcohol que contiene uno o más grupos hidroxilo para producir una preparación entérica para el tratamiento de la obesidad.
ES86907000T 1985-11-25 1986-11-24 Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica. Expired - Lifetime ES2018479B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505569A SE8505569D0 (sv) 1985-11-25 1985-11-25 Enteralt preparat

Publications (1)

Publication Number Publication Date
ES2018479B3 true ES2018479B3 (es) 1991-04-16

Family

ID=20362239

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86907000T Expired - Lifetime ES2018479B3 (es) 1985-11-25 1986-11-24 Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica.

Country Status (11)

Country Link
EP (2) EP0225303A1 (es)
JP (1) JP2608402B2 (es)
KR (1) KR880700664A (es)
AU (1) AU595276B2 (es)
DE (1) DE3673998D1 (es)
DK (1) DK386287D0 (es)
ES (1) ES2018479B3 (es)
GR (1) GR3000834T3 (es)
PH (1) PH23944A (es)
SE (1) SE8505569D0 (es)
WO (1) WO1987003198A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903232B2 (ja) * 1990-01-09 1999-06-07 株式会社アドバンス 脂質吸収阻害剤
FR2663222A1 (fr) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule de liquide huileux.
US5322697A (en) 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
AU2745301A (en) * 2000-01-07 2001-07-24 Monsanto Technology Llc Low calorie fat compositions
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
IL158131A0 (en) 2001-03-27 2004-03-28 Univ California Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
AU2003209750A1 (en) * 2002-03-30 2003-10-13 Gunther Beisel Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
SE0203886D0 (sv) * 2002-12-27 2002-12-27 Ltp Lipid Technologies Provide Glycerolesterprodukt och dess användning
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
WO2007115899A1 (en) * 2006-04-07 2007-10-18 Unilever N.V. Satiety enhancing food products
WO2009144268A1 (en) * 2008-05-30 2009-12-03 Dsm Ip Assets B.V. Composition for increasing gastrointestinal transit time
US9757346B2 (en) 2008-09-03 2017-09-12 Volant Holdings Gmbh Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
CN102438599B (zh) * 2009-03-04 2015-01-21 迈雅营养品有限公司 通过降低血糖水平来控制糖尿病的营养组合物和方法
US8530514B2 (en) 2009-04-03 2013-09-10 Dsm Ip Assets B.V. Satiety-inducing composition
PL2575768T3 (pl) 2010-05-24 2018-07-31 Swedish Oat Fiber Ab Wodna dyspersja zawierająca galaktolipidy oraz sposób jej wytwarzania
CN115569117A (zh) * 2014-08-11 2023-01-06 佩罗拉股份有限公司 诱导饱腹感的方法
HUE047839T2 (hu) 2014-08-11 2020-05-28 Perora Gmbh Szemcséket tartalmazó készítmény
US11234935B2 (en) 2015-07-07 2022-02-01 Perora Gmbh Method of inducing satiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4195M (es) * 1965-02-15 1966-05-31
DE2344958A1 (de) * 1973-09-06 1975-03-20 Hans Dr Zahn Appetitzuegler
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
JPS59175425A (ja) * 1983-03-25 1984-10-04 Otsuka Pharmaceut Co Ltd 脳卒中予防剤
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid

Also Published As

Publication number Publication date
EP0246294A1 (en) 1987-11-25
JP2608402B2 (ja) 1997-05-07
EP0225303A1 (en) 1987-06-10
KR880700664A (ko) 1988-04-11
PH23944A (en) 1990-01-23
JPS63501425A (ja) 1988-06-02
GR3000834T3 (en) 1991-11-15
WO1987003198A1 (en) 1987-06-04
SE8505569D0 (sv) 1985-11-25
DK386287A (da) 1987-07-24
DK386287D0 (da) 1987-07-24
AU595276B2 (en) 1990-03-29
AU6724487A (en) 1987-07-01
DE3673998D1 (de) 1990-10-11
EP0246294B1 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
ES2018479B3 (es) Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica.
SE8405929D0 (sv) Farmaceutisk komposition
ES2060158T3 (es) Uso de alcoholes alifaticos c-22 a c-26 en el tratamiento de enfermedades de la piel inflamatorias y viricas.
DOP1990004773A (es) Nueva forma del ester de cefruroxima, procedimiento para su preparacion y composicion que la coantene
AR219872A1 (es) Procedimiento de preparacion de bebidas fermentadas de concentracion de alcohol reducida y dispositivo para ponerlo en practica
ATE7856T1 (de) Gamma-linolensaeuren enthaltende pharmazeutische und diaetetische zusammensetzung.
IT1200217B (it) Membrana per uso farmaceutico ed industriale
PT83474B (pt) Processo de preparacao de uma composicao farmaceutica compreendendo o acido -2(2-fluoro-4-bifenilil)propionico ou um seu sal farmaceuticamente aceitavel
DE3775922D1 (de) Kosmetische zubereitungen, die elastinderivate enthalten.
ES502286A0 (es) Procedimiento para la preparacion de una mezcla de un este- roide anti-inflamatorio y un fluoro-cloro-hidrocarburo para ser utilizado como propulsor
ATE77047T1 (de) Sebosuppressive topische zubereitungen.
ES2059492T3 (es) Procedimiento para la preparacion de ibuprofen.
YU47192A (sh) Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje
IL77010A (en) 12-hydroxystearic acid diesters,process for the preparation thereof and cosmetic preparations containing the same
SE7905659L (sv) Medel for behandling av seborreiska tillstand
IL45244A0 (en) Method for the preparation of unsaturated linear substituted acids and saturated or unsaturated derivatives thereof
SE8101267L (sv) Nya acylderivat av karnitin, forfarande for deras framstellning och terapeutisk anvendning av dem
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
DE3061357D1 (en) Preparation of esters containing an alpha cyano group in the alcohol portion of the ester
ES554320A0 (es) Un procedimiento para preparar esteres de acidos ciclopropanocarboxolico que contienen fluor.
ES2065343T3 (es) Nuevos preparados farmaceuticos asi como nuevos compuestos de lactosilo y su preparacion.
ES2026485T3 (es) Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas.
ES2089276T5 (es) Metodo de preparacion del ester metilico de la alfa-l-aspartil-l-fenilalanina.
ES2033258T3 (es) Procedimiento para preparar una composicion para sistema terapeuticos transdermales.